Carl Webster has a BSc in biochemistry from Bath University and a PhD in Molecular Biology from Leicester University. He followed his education with a post doc position at Cambridge University on the role of high mobility group proteins in gene regulation.
Carl was recruited to CAT in 1997. In 2000 he set up CAT’s antigen expression and molecular biology team providing gene cloning, and expression technologies for antigens and scFv to CAT’s drug programmes. He is now Principal Scientist, ADPE for MedImmune, leading teams using protein engineering for the development of novel therapeutics and for blood brain barrier transport.